192 related articles for article (PubMed ID: 18645122)
1. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
2. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
[TBL] [Abstract][Full Text] [Related]
3. Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey.
Bektas-Kayhan K; Unür M; Yaylim-Eraltan I; Ergen A; Hafiz G; Karadeniz A; Isbir T
Anticancer Res; 2009 Jul; 29(7):2519-24. PubMed ID: 19596922
[TBL] [Abstract][Full Text] [Related]
4. MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients.
Bhattacharya N; Roy A; Roy B; Roychoudhury S; Panda CK
J Oral Pathol Med; 2009 Nov; 38(10):759-63. PubMed ID: 19453846
[TBL] [Abstract][Full Text] [Related]
5. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy in nonmelanoma skin cancer.
Robinson JK; Rademaker AW; Goolsby C; Traczyk TN; Zoladz C
Cancer; 1996 Jan; 77(2):284-91. PubMed ID: 8625236
[TBL] [Abstract][Full Text] [Related]
7. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
[TBL] [Abstract][Full Text] [Related]
8. Restriction fragment length polymorphism of the L-myc gene is not a prognostic factor in bladder cancer patients.
Ejarque MJ; Vicente M; Bernués M; Oliver A; Vicente J; Capellá G; Lluís F; Chéchile G
Br J Cancer; 1999 Apr; 79(11-12):1855-8. PubMed ID: 10206304
[TBL] [Abstract][Full Text] [Related]
9. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
Asefi V; Mojtahedi Z; Khademi B; Naeimi S; Ghaderi A
J Laryngol Otol; 2009 Apr; 123(4):444-8. PubMed ID: 18940019
[TBL] [Abstract][Full Text] [Related]
10. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization.
Kanjilal S; Strom SS; Clayman GL; Weber RS; el-Naggar AK; Kapur V; Cummings KK; Hill LA; Spitz MR; Kripke ML
Cancer Res; 1995 Aug; 55(16):3604-9. PubMed ID: 7627969
[TBL] [Abstract][Full Text] [Related]
11. L-myc gene polymorphism and risk of thyroid cancer.
Yaylim-Eraltan I; Bozkurt N; Ergen A; Zeybek U; Ozturk O; Arikan S; Erbil Y; Uslu I; Camlica H; Isbir T
Exp Oncol; 2008 Jun; 30(2):117-20. PubMed ID: 18566574
[TBL] [Abstract][Full Text] [Related]
12. L-myc restriction fragment length polymorphism and histological pattern of invasion in lung adenocarcinoma.
Suzuki H; Yamashiro K
Oncol Rep; 2002; 9(2):345-7. PubMed ID: 11836605
[TBL] [Abstract][Full Text] [Related]
13. Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population.
Csejtei A; Tibold A; Koltai K; Varga Z; Szanyi I; Gobel G; Prantner I; Steffler D; Feher G; De Blasio A; Ember I; Kiss I
Anticancer Res; 2009 Oct; 29(10):4169-73. PubMed ID: 19846968
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
[TBL] [Abstract][Full Text] [Related]
15. Analysis of L-myc gene polymorphism in patients with renal failure outcome to renal transplant.
Yigit B; Bozkurt N; Yaylim I; Titiz I; Isbir T
Transplant Proc; 2006 Jun; 38(5):1267-9. PubMed ID: 16797278
[TBL] [Abstract][Full Text] [Related]
16. A case-control study on the effect of apoliprotein E genotype on head and neck cancer risk.
De Feo E; Rowell J; Cadoni G; Nicolotti N; Arzani D; Giorgio A; Amore R; Paludetti G; Ricciardi G; Boccia S
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2839-46. PubMed ID: 20861397
[TBL] [Abstract][Full Text] [Related]
17. L-MYC and GSTM1 polymorphisms are associated with unfavourable clinical parameters of gliomas.
Kondratieva TV; Imyanitov EN; Togo AV; Zaitseva OA; Yatsuk OS; Romanenko SM; Bersnev VP; Hanson KP
J Exp Clin Cancer Res; 2000 Jun; 19(2):197-200. PubMed ID: 10965818
[TBL] [Abstract][Full Text] [Related]
18. Frequencies of ADH1C alleles and genotypes in a Turkish head and neck cancer population.
Kortunay S; Koseler A; Orhan Kara C; Topuz B; Omer Atalay E
Methods Find Exp Clin Pharmacol; 2010 Apr; 32(3):187-91. PubMed ID: 20448861
[TBL] [Abstract][Full Text] [Related]
19. [L-myc and GSTM1 polymorphism in cerebral glioma].
Kondrat'eva TV; Imianitov EN; Togo AV; Zaĭtseva OA; Iatsuk OS; Bersnev VP; Khanson KP
Vopr Onkol; 1999; 45(5):523-7. PubMed ID: 10629710
[TBL] [Abstract][Full Text] [Related]
20. Nonmelanoma skin cancer of the head and neck: molecular mechanisms.
Cobanoglu HB; Constantinides M; Ural A
Facial Plast Surg Clin North Am; 2012 Nov; 20(4):437-43. PubMed ID: 23084296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]